The biological pathways of Alzheimer disease: A review

M Calabrò, C Rinaldi, G Santoro… - AIMS …, 2020 - pmc.ncbi.nlm.nih.gov
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older
people, which severely impairs patients' quality of life. In the recent years, the number of …

Altered metabolism in Alzheimer disease brain: role of oxidative stress

NG Rummel, DA Butterfield - Antioxidants & Redox Signaling, 2022 - liebertpub.com
Significance: Alzheimer disease (AD) is an all-too-common condition in the aging
population. However, aging does not automatically equal neurodegeneration and memory …

Delivering the promise of gene therapy with nanomedicines in treating central nervous system diseases

M Luo, LKC Lee, B Peng, CHJ Choi… - Advanced …, 2022 - Wiley Online Library
Abstract Central Nervous System (CNS) diseases, such as Alzheimer's diseases (AD),
Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain …

ER-resident STIM1/2 couples Ca2+ entry by NMDA receptors to pannexin-1 activation

CS Patil, H Li, NE Lavine, R Shi… - Proceedings of the …, 2022 - National Acad Sciences
Pannexin-1 (Panx1) is a large-pore ion and solute permeable channel highly expressed in
the nervous system, where it subserves diverse processes, including neurite outgrowth …

Probenecid, an old drug with potential new uses for central nervous system disorders and neuroinflammation

C García-Rodríguez, P Mujica, J Illanes-González… - Biomedicines, 2023 - mdpi.com
Probenecid is an old uricosuric agent used in clinics to treat gout and reduce the renal
excretion of antibiotics. In recent years, probenecid has gained attention due to its ability to …

SIRT1 is involved in the neuroprotection of pterostilbene against amyloid β 25–35-induced cognitive deficits in mice

L Zhu, F Lu, X Zhang, S Liu, P Mu - Frontiers in pharmacology, 2022 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
amyloid-β (Aβ) deposits and neurofibrillary tangles. Pterostilbene (PTE), a bioactive …

Purinergic signaling in nervous system health and disease: Focus on pannexin 1

JC Sanchez-Arias, E van der Slagt… - Pharmacology & …, 2021 - Elsevier
Purinergic signaling encompasses the cycle of adenosine 5′ triphosphate (ATP) release
and its metabolism into nucleotide and nucleoside derivatives, the direct release of …

Redox modifications in synaptic components as biomarkers of cognitive status, in brain aging and disease

P Muñoz, ÁO Ardiles, B Pérez-Espinosa… - Mechanisms of ageing …, 2020 - Elsevier
Aging is a natural process that includes several changes that gradually make organisms
degenerate and die. Harman's theory proposes that aging is a consequence of the …

Absence of Pannexin 1 stabilizes hippocampal excitability after intracerebral treatment with Aβ (1-42) and prevents LTP deficits in middle-aged mice

N Südkamp, O Shchyglo… - Frontiers in Aging …, 2021 - frontiersin.org
Beta-amyloid protein [Aβ (1-42)] plays an important role in the disease progress and
pathophysiology of Alzheimer's disease (AD). Membrane properties and neuronal …

Serum levels of neurotensin, pannexin-1, and sestrin-2 and the correlations with sleep quality or/and cognitive function in the patients with chronic insomnia disorder

AX Su, ZJ Ma, ZY Li, XY Li, L Xia, YJ Ge… - Frontiers in …, 2024 - frontiersin.org
Objectives To examine serum concentrations of neurotensin, pannexin-1 and sestrin-2, and
their correlations with subjective and objective sleep quality and cognitive function in the …